Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aileen Roth

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Frontiers in Pharmacology|September 27, 2023
Zebrafish as model system for the biological characterization of CK1 inhibitorsLaura Meier, Bernd Martin Gahr, Aileen Roth, et al.
Archiv Der Pharmazie|February 17, 2022
C5-Iminosugar modification of casein kinase 1δ lead 3-(4-fluorophenyl)-5-isopropyl-4-(pyridin-4-yl)isoxazole promotes enhanced inhibitor affinity and selectivityThorsten von Drathen, Elizabeth M Ure, Stefan Kirschner, et al.
Journal of Medicinal Chemistry|November 8, 2022
Phenotypic Discovery of Triazolo[1,5-<i>c</i>]quinazolines as a First-In-Class Bone Morphogenetic Protein Amplifier ChemotypeFabian Wesseler, Stefan Lohmann, Daniel Riege, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Frontiers in Pharmacology|September 27, 2023
Zebrafish as model system for the biological characterization of CK1 inhibitorsLaura Meier, Bernd Martin Gahr, Aileen Roth, et al.
Archiv Der Pharmazie|February 17, 2022
C5-Iminosugar modification of casein kinase 1δ lead 3-(4-fluorophenyl)-5-isopropyl-4-(pyridin-4-yl)isoxazole promotes enhanced inhibitor affinity and selectivityThorsten von Drathen, Elizabeth M Ure, Stefan Kirschner, et al.
Journal of Medicinal Chemistry|November 8, 2022
Phenotypic Discovery of Triazolo[1,5-<i>c</i>]quinazolines as a First-In-Class Bone Morphogenetic Protein Amplifier ChemotypeFabian Wesseler, Stefan Lohmann, Daniel Riege, et al.
Pageof 2